Salivary and serum levels of substance p, neurokinin A and calcitonin gene related peptide in burning mouth syndrome

No significant differences in salivary SP, NKA and CGRP as well as serum SP and CGRP between BMS patients and controls could be found. However, significantly decreased serum neurokinin A (p<0.05) in BMS patients may reflect an inefficient dopaminergic system.